P1679: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR): RESULTS FROM THE PHASE 3 ASPEN TRIAL LONG-TERM FOLLOW-UP

Detalles Bibliográficos
Autores principales: Tedeschi, Alessandra, Tam, Constantine, Owen, Roger, Buske, Christian, Leblond, Véronique, Dimopoulos, Meletios A., García-Sanz, Ramón, Castillo, Jorge, Trotman, Judith, Treon, Steven, Yang, Keri, Tang, Boxiong, Allewelt, Heather, Patel, Sheel, Chan, Wai, Cohen, Aileen, Schneider, Jingjing Yan, Barnes, Gisoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430046/
http://dx.doi.org/10.1097/01.HS9.0000973588.27391.ea

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430046/
http://dx.doi.org/10.1097/01.HS9.0000973588.27391.ea

Ejemplares similares